» Articles » PMID: 25875108

Deletion of Histone Deacetylase 7 in Osteoclasts Decreases Bone Mass in Mice by Interactions with MITF

Overview
Journal PLoS One
Date 2015 Apr 16
PMID 25875108
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Molecular regulators of osteoclast formation and function are an important area of research due to the central role of osteoclasts in bone resorption. Transcription factors such as MITF are essential for osteoclast generation by regulating expression of the genes required for cellular differentiation and resorptive function. We recently reported that histone deacetylase 7 (HDAC7) binds to and represses the transcriptional activity of MITF in osteoclasts, and that loss of HDAC7 in vitro accelerated osteoclastogenesis. In the current study, we extend this initial observation by showing that conditional deletion of HDAC7 in osteoclasts of mice leads to an in vivo enhancement in osteoclast formation, associated with increased bone resorption and lower bone mass. Expression of multiple MITF target genes is increased in bone marrow derived osteoclast cultures from the HDAC7 knockout mice. Interestingly, multiple regions of the HDAC7 amino-terminus can bind to MITF or exert repressive activity. Moreover, mutation or deletion of the HDAC7 conserved deacetylase catalytic domain had little effect on repressive function. These observations identify HDAC7 in osteoclasts as an important molecular regulator of MITF activity and bone homeostasis, but also highlight a gap in our understanding of exactly how HDAC7 functions as a corepressor.

Citing Articles

Lysine specific demethylase 1 conditional myeloid cell knockout mice have decreased osteoclast differentiation due to increased IFN- gene expression.

Astleford-Hopper K, Abrahante Llorens J, Bradley E, Mansky K JBMR Plus. 2024; 9(1):ziae142.

PMID: 39664933 PMC: 11632826. DOI: 10.1093/jbmrpl/ziae142.


Unlocking the Epigenetic Symphony: Histone Acetylation Orchestration in Bone Remodeling and Diseases.

Cai J, Deng Y, Min Z, Li C, Zhao Z, Yi J Stem Cell Rev Rep. 2024; 21(2):291-303.

PMID: 39495465 DOI: 10.1007/s12015-024-10807-2.


Differential Gene Expression Involved in Bone Turnover of Mice Expressing Constitutively Active TGFβ Receptor Type I.

Myint O, Sakunrangsit N, Pholtaisong J, Toejing P, Pho-On P, Leelahavanichkul A Int J Mol Sci. 2024; 25(11).

PMID: 38892016 PMC: 11173332. DOI: 10.3390/ijms25115829.


Microbiota metabolites in bone: Shaping health and Confronting disease.

Han D, Wang W, Gong J, Ma Y, Li Y Heliyon. 2024; 10(7):e28435.

PMID: 38560225 PMC: 10979239. DOI: 10.1016/j.heliyon.2024.e28435.


The role of DNA methylation on gene expression in the vertebrae of ancestrally benzo[a]pyrene exposed F1 and F3 male medaka.

Wan T, Mo J, Au D, Qin X, Tam N, Kong R Epigenetics. 2023; 18(1):2222246.

PMID: 37322851 PMC: 10281469. DOI: 10.1080/15592294.2023.2222246.


References
1.
Malik S, Jiang S, Garee J, Verdin E, Lee A, OMalley B . Histone deacetylase 7 and FoxA1 in estrogen-mediated repression of RPRM. Mol Cell Biol. 2009; 30(2):399-412. PMC: 2798473. DOI: 10.1128/MCB.00907-09. View

2.
Ma C, DMello S . Neuroprotection by histone deacetylase-7 (HDAC7) occurs by inhibition of c-jun expression through a deacetylase-independent mechanism. J Biol Chem. 2010; 286(6):4819-28. PMC: 3039335. DOI: 10.1074/jbc.M110.146860. View

3.
Pham L, Kaiser B, Romsa A, Schwarz T, Gopalakrishnan R, Jensen E . HDAC3 and HDAC7 have opposite effects on osteoclast differentiation. J Biol Chem. 2011; 286(14):12056-65. PMC: 3069409. DOI: 10.1074/jbc.M110.216853. View

4.
McGee-Lawrence M, McCleary-Wheeler A, Secreto F, Razidlo D, Zhang M, Stensgard B . Suberoylanilide hydroxamic acid (SAHA; vorinostat) causes bone loss by inhibiting immature osteoblasts. Bone. 2011; 48(5):1117-26. PMC: 3079070. DOI: 10.1016/j.bone.2011.01.007. View

5.
Mansky K, Sulzbacher S, Purdom G, Nelsen L, Hume D, Rehli M . The microphthalmia transcription factor and the related helix-loop-helix zipper factors TFE-3 and TFE-C collaborate to activate the tartrate-resistant acid phosphatase promoter. J Leukoc Biol. 2002; 71(2):304-10. View